Summer City Connections: Boston - Dine & Discuss: What Being an Analyst Really Means

Date
Jun 22, 2024, 11:00 am1:00 pm
Location
Boston, MA
Audience
  • Alumni
  • Graduate Students
  • Undergraduate Students

Details

Event Description

"Analyst" is a common title for many folks' first jobs after college across a range of industries including finance, consulting, research, life sciences and more.

But what does being an analyst really mean? Find out from recent alumni whose careers began as analysts in different industries.

Enjoy brunch and learn from Anna Dong '20 and Dani Peters '20 about their career paths and what working as analysts looks like for them. Space is limited so sign up to reserve your spot.

Summer City Connections is a location-based program designed to foster relationships and professional development among current Princeton students, recent graduates and alumni during the summer.

Alumni panelists

Anna Dong '20

Anna Dong '20

Anna Dong is an investment analyst at Bracebridge Capital where she helped establish the firm’s environmental commodities portfolio. At Princeton, she majored in operations research and financial engineering with certificates in statistics and machine learning and engineering and management systems. After graduation, she spent a summer researching sustainable agricultural practices before beginning her career in finance. Her first role was in commercial real estate before she shifted to her current focus in energy transition finance.

 

 

 

 

 

Dani Peters '20

Dani Peters '20

Dani concentrated in molecular biology with a certificate in Spanish language and culture before joining ClearView Healthcare Partners as a healthcare and life sciences consulting analyst in August 2020. In this position, she has worked with pharmaceutical and biotechnology companies of all shapes and sizes to assist with problem solving and guide business decision making related to drug and device development and commercialization. Dani held this role for just under four years before making a recent pivot to the industry side with a biotech portfolio strategy position.